Cargando…
Harnessing the CRISPR-Cas Systems to Combat Antimicrobial Resistance
The emergence of antimicrobial-resistant (AMR) bacteria has become one of the most serious threats to global health, necessitating the development of novel antimicrobial strategies. CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) system, known as a bacteria...
Autores principales: | Duan, Cheng, Cao, Huiluo, Zhang, Lian-Hui, Xu, Zeling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418092/ https://www.ncbi.nlm.nih.gov/pubmed/34489905 http://dx.doi.org/10.3389/fmicb.2021.716064 |
Ejemplares similares
-
How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance
por: Gholizadeh, Pourya, et al.
Publicado: (2020) -
Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics
por: Chan, Kok Gan, et al.
Publicado: (2021) -
Enlarging the Toolbox Against Antimicrobial Resistance: Aptamers and CRISPR-Cas
por: Pereira, Higor Sette, et al.
Publicado: (2021) -
Editorial: The CRISPR/Cas System in Pathogen Resistance, Virulence, Diagnosis and Typing
por: Duan, Guangcai, et al.
Publicado: (2022) -
Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects
por: Li, Yingjun, et al.
Publicado: (2019)